CASI - CASI Pharmaceuticals EPS misses by $0.06 beats on revenue March, 30 2021 07:33 AM CASI Pharmaceuticals Inc. CASI Pharmaceuticals (CASI): FY GAAP EPS of -$0.44 misses by $0.06.Revenue of $15M (+263.2% Y/Y) beats by $0.31M.Shares +1.01% PM.Press Release For further details see: CASI Pharmaceuticals EPS misses by $0.06, beats on revenue